Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. 1991

H Adler-Mosca, and J Lüthy-Hottenstein, and G Martinetti Lucchini, and A Burnens, and M Altwegg
Department of Medical Microbiology, University of Zurich, Switzerland.

Development of resistance to nalidixic acid, norfloxacin and ciprofloxacin was observed in five patients with Campylobacter jejuni or Campylobacter coli infection. From all these patients nalidixic acid- and quinolone-susceptible strains were isolated initially, whereas after therapy with norfloxacin or ciprofloxacin strains resistant to these antibiotics were found. Campylobacter strains from the same patient always belonged to the same species and, with the exception of one case, showed identical rRNA gene restriction (rDNA) patterns. This indicates that double-infection with a susceptible and a resistant strain was not responsible for the phenomenon but rather that the infecting strain rapidly developed resistance following treatment.

UI MeSH Term Description Entries
D008297 Male Males
D009268 Nalidixic Acid A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. Nalidixin,Nalidixate Sodium,Nalidixate Sodium Anhydrous,Nevigramon,Sodium Nalidixic Acid, Anhydrous,Sodium Nalidixic Acid, Monohydrate,Acid, Nalidixic,Anhydrous, Nalidixate Sodium,Sodium Anhydrous, Nalidixate,Sodium, Nalidixate
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D002169 Campylobacter Infections Infections with bacteria of the genus CAMPYLOBACTER. Campylobacter Infection,Campylobacteriosis,Infections, Campylobacter,Campylobacterioses,Infection, Campylobacter
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D004275 DNA, Ribosomal DNA sequences encoding RIBOSOMAL RNA and the segments of DNA separating the individual ribosomal RNA genes, referred to as RIBOSOMAL SPACER DNA. Ribosomal DNA,rDNA
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Adler-Mosca, and J Lüthy-Hottenstein, and G Martinetti Lucchini, and A Burnens, and M Altwegg
January 1990, Scandinavian journal of infectious diseases. Supplementum,
H Adler-Mosca, and J Lüthy-Hottenstein, and G Martinetti Lucchini, and A Burnens, and M Altwegg
December 1990, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
H Adler-Mosca, and J Lüthy-Hottenstein, and G Martinetti Lucchini, and A Burnens, and M Altwegg
January 1991, Chemotherapy,
H Adler-Mosca, and J Lüthy-Hottenstein, and G Martinetti Lucchini, and A Burnens, and M Altwegg
January 1988, European journal of cancer & clinical oncology,
H Adler-Mosca, and J Lüthy-Hottenstein, and G Martinetti Lucchini, and A Burnens, and M Altwegg
May 1999, Antimicrobial agents and chemotherapy,
H Adler-Mosca, and J Lüthy-Hottenstein, and G Martinetti Lucchini, and A Burnens, and M Altwegg
May 2005, The Journal of infectious diseases,
H Adler-Mosca, and J Lüthy-Hottenstein, and G Martinetti Lucchini, and A Burnens, and M Altwegg
January 2018, Frontiers in microbiology,
H Adler-Mosca, and J Lüthy-Hottenstein, and G Martinetti Lucchini, and A Burnens, and M Altwegg
December 2023, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
H Adler-Mosca, and J Lüthy-Hottenstein, and G Martinetti Lucchini, and A Burnens, and M Altwegg
May 2001, International journal of antimicrobial agents,
H Adler-Mosca, and J Lüthy-Hottenstein, and G Martinetti Lucchini, and A Burnens, and M Altwegg
January 1992, Scandinavian journal of infectious diseases,
Copied contents to your clipboard!